Metraipolis › archive › dc_e64dbe61c07e

The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms… — Europe PMC PMID:41710895

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41710895
DOI
10.3389/fimmu.2026.1757711
License (as archived)
solo-consultazione
Archived
2026-11-06T04:04:47.725Z
SHA-256 of the archived text
5115953d3d3414c1082140ecd36d82f3a6fb750702637179861b3427fc632801
Stable URL of this page
https://metraipolis.com/documento/dc_e64dbe61c07e

How to cite

The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms… — Europe PMC PMID:41710895 — Europe PMC (en), https://europepmc.org/article/MED/41710895 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e64dbe61c07e (Metraipolis archive dc_e64dbe61c07e, sha256 5115953d3d3414c1082140ecd36d82f3a6fb750702637179861b3427fc632801)
BibTeX
@misc{dce64dbe61c07e,
  title = {The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms… — Europe PMC PMID:41710895},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41710895},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e64dbe61c07e; sha256 5115953d3d3414c1082140ecd36d82f3a6fb750702637179861b3427fc632801},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41710895. Agents can read the archived copy with the MCP tool read_document.